Driada Medical IGF-1 LR3

£45.00

Description
Reviews (0)

Driada Medical IGF-1 LR3

Driada Medical IGF-1 LR3 is a synthetic analog of Insulin-like Growth Factor 1 featuring the Long R3 modification, a structural alteration that drastically reduces binding to IGF binding proteins (IGFBPs) while extending half-life. This peptide is engineered for athletes seeking permanent muscle density increases through hyperplasia—the formation of new muscle fibers—rather than temporary hypertrophy of existing cells. The compound accelerates protein synthesis, enhances nitrogen retention, and drives nutrient partitioning into muscle tissue with anabolic potency significantly exceeding native IGF-1. Its unique structure allows for sustained activity in the bloodstream, delivering continuous anabolic signaling that supports rapid recovery from injuries and intense physical stress. Unlike standard growth factors that bind quickly to plasma proteins and degrade, the LR3 variant circulates longer, reaching target tissues more effectively to stimulate satellite cell activation and glucose uptake.

Key Features

Contains synthetic IGF-1 LR3 (Insulin-like Growth Factor 1 Long R3)
Structural modification reduces IGFBP binding, extending half-life significantly
Promotes muscle hyperplasia (new fiber formation) beyond simple hypertrophy
Accelerates protein synthesis and nitrogen retention in skeletal muscle
Enhances glucose uptake and nutrient partitioning into muscle cells
Supports rapid recovery from injuries and connective tissue repair
Requires subcutaneous or intramuscular administration
Manufactured by Driada Medical under strict pharmaceutical quality standards

Where to Buy

Available through specialized peptide distributors and verified research suppliers
Purchase only from sources providing batch verification codes and holographic seals
Verify authenticity via the official Driada Medical portal before administration
Request Certificate of Analysis (COA) to confirm purity and amino acid sequence
Avoid unregulated markets containing degraded, oxidized, or mislabeled peptides

Product Specifications

Active Ingredient: IGF-1 LR3 (Recombinant)
Concentration: Typically 1mg/vial (varies by preparation)
Form: Lyophilized powder requiring reconstitution with sterile or bacteriostatic water
Package Size: Single vial (multi-dose)
Storage: Lyophilized stable at 2-8°C; reconstituted solution stable 14-30 days refrigerated
Half-life: Approximately 20-30 hours (significantly longer than native IGF-1)
Administration: Subcutaneous or intramuscular injection
Detection Time: Prohibited by WADA; detectable in advanced peptide screening protocols

Mechanism of Action

IGF-1 LR3 binds to IGF-1 receptors on muscle cell membranes with high affinity. The Long R3 modification replaces glutamic acid at position 3 with arginine and adds 13 amino acids to the N-terminus, preventing binding to inhibitory IGF binding proteins. This allows the peptide to circulate longer and reach target tissues more effectively. Once bound, it activates the PI3K/Akt signaling pathway, stimulating protein synthesis and inhibiting apoptosis. It activates satellite cells, triggering muscle fiber hyperplasia. The compound enhances glucose transport into cells via upregulation of GLUT4 transporters, mimicking insulin action but with specific anabolic focus on muscle tissue.

Metabolic Impact

The peptide drastically increases nitrogen retention and protein synthesis rates, creating a highly anabolic environment. It shifts nutrient partitioning toward muscle cells, increasing glycogen storage and amino acid uptake while promoting lipolysis in adipose tissue. Users experience enhanced recovery as the compound accelerates cellular repair and reduces inflammation. However, it can induce hypoglycemia by increasing glucose uptake, requiring blood sugar monitoring. The metabolic shift supports simultaneous muscle gain and fat loss, though the risk of organ growth (heart, intestines) exists with prolonged use due to IGF-1 receptors present in all tissues.

Conclusion

Driada Medical IGF-1 LR3 represents a powerful tool for athletes seeking permanent muscle density increases through hyperplasia. Its extended half-life and potent anabolic signaling make it superior to standard growth factors for physique enhancement. However, its potency demands precise dosing, strict refrigeration protocols, and awareness of systemic risks including hypoglycemia and potential cellular proliferation beyond muscle tissue.

Safety Warning

IGF-1 LR3 carries severe risks including hypoglycemia, organ growth (cardiac hypertrophy, intestinal enlargement), and potential cancer promotion due to mitogenic effects on all cells. Side effects include joint pain, water retention, and numbness. This product is not for recreational use. Consult a licensed physician before administration. Do not use if pregnant, nursing, under 21, or with history of cancer. Regular blood glucose monitoring is mandatory. This information is provided for educational purposes only. Actually using this product without medical supervision is illegal in many jurisdictions and could land you in serious legal trouble.